Search alternatives:
significantly mitigated » significantly mediated (Expand Search), significantly elevated (Expand Search), significantly related (Expand Search)
mitigated decrease » estimated decrease (Expand Search)
increase decrease » increased release (Expand Search), increased crash (Expand Search)
significantly mitigated » significantly mediated (Expand Search), significantly elevated (Expand Search), significantly related (Expand Search)
mitigated decrease » estimated decrease (Expand Search)
increase decrease » increased release (Expand Search), increased crash (Expand Search)
-
1481
-
1482
Incidence number, ASIR under the age of 20 in 204 countries and territories in 2021.
Published 2025Subjects: -
1483
-
1484
DALYs number, ASDR under the age of 20 in 204 countries and territories in 2021.
Published 2025Subjects: -
1485
-
1486
-
1487
-
1488
-
1489
-
1490
-
1491
-
1492
-
1493
-
1494
Trends analysis in diabetes mellitus diagnosis according to relative handgrip strength.
Published 2024Subjects: -
1495
-
1496
Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
-
1497
Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
-
1498
Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
-
1499
Schematic overview of the experimental groups.
Published 2025“…LDL-C, total cholesterol, serum and hepatic triglycerides, visceral adipose, and hepatic mass and steatosis were also significantly decreased in the test group compared to negative control group (p < 0.01).…”
-
1500
Table 1_Soil properties and rhizosphere interactions affecting nitrous oxide emissions with mitigation by nitrification inhibitors in rice growth stages.docx
Published 2025“…These findings highlight the efficacy of NIs in significantly mitigating N<sub>2</sub>O emissions, particularly in rhizosphere soils. …”